APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Outlook and Growth Opportunities 2026

Report ID 17401983042 January 2026204 pages

Choose your research edition.

Industry ResearchOral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market include Biomatlante, Biomedical Tissues, Bio-tech, Botiss, Dentsply Sirona, Geistlich Pharma, Genoss, Keystone Dental and Lynch Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Segment by Company

Biomatlante

Biomedical Tissues

Bio-tech

Botiss

Dentsply Sirona

Geistlich Pharma

Genoss

Keystone Dental

Lynch Biologics

MegaGen Impant

Neoss Limited

Nobel Biocare Services/Danaher Corporation

OraPharma

Salvin Dental Specialties，Inc

Sunstar

Yantai Zhenghai Bio-tech

Zimmer Biomet

Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Segment by Type

Absorbable Membrane

Non-resorbable Membrane

Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Segment by Application

Dental

Hospital

Clinic

Other

Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane significant trends, drivers, influence factors in global and regions.

6. To analyze Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane industry.

Chapter 3: Detailed analysis of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Trends Table 2. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Drivers Table 3. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Opportunities and Challenges Table 4. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Restraints Table 5. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue Share by Company (2021-2026) Table 7. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Company (2021-2026) Table 9. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Key Company Manufacturing Base & Headquarters Table 12. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Company, Product Type & Application Table 13. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Absorbable Membrane Table 18. Significant Companies of Non-resorbable Membrane Table 19. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Type (2021-2026) Table 23. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Type (2027-2032) Table 24. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type (2021-2026) Table 28. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Dental Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Other Table 33. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Application (2021-2026) Table 37. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Application (2027-2032) Table 38. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application (2021-2026) Table 42. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application (2027-2032) Table 43. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region (2021-2026) & (K Units) Table 45. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Region (2021-2026) Table 46. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region (2027-2032) & (K Units) Table 47. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Region (2027-2032) Table 48. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Region (2021-2026) Table 51. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Region (2027-2032) Table 53. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Country (2021-2026) & (K Units) Table 58. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Country (2021-2026) Table 59. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Country (2027-2032) & (K Units) Table 60. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Country (2027-2032) Table 61. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Market Share by Country (2021-2026) Table 63. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Market Share by Country (2027-2032) Table 65. Biomatlante Company Information Table 66. Biomatlante Business Overview Table 67. Biomatlante Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Biomatlante Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 69. Biomatlante Recent Development Table 70. Biomedical Tissues Company Information Table 71. Biomedical Tissues Business Overview Table 72. Biomedical Tissues Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Biomedical Tissues Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 74. Biomedical Tissues Recent Development Table 75. Bio-tech Company Information Table 76. Bio-tech Business Overview Table 77. Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 79. Bio-tech Recent Development Table 80. Botiss Company Information Table 81. Botiss Business Overview Table 82. Botiss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Botiss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 84. Botiss Recent Development Table 85. Dentsply Sirona Company Information Table 86. Dentsply Sirona Business Overview Table 87. Dentsply Sirona Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Dentsply Sirona Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 89. Dentsply Sirona Recent Development Table 90. Geistlich Pharma Company Information Table 91. Geistlich Pharma Business Overview Table 92. Geistlich Pharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Geistlich Pharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 94. Geistlich Pharma Recent Development Table 95. Genoss Company Information Table 96. Genoss Business Overview Table 97. Genoss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Genoss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 99. Genoss Recent Development Table 100. Keystone Dental Company Information Table 101. Keystone Dental Business Overview Table 102. Keystone Dental Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Keystone Dental Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 104. Keystone Dental Recent Development Table 105. Lynch Biologics Company Information Table 106. Lynch Biologics Business Overview Table 107. Lynch Biologics Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Lynch Biologics Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 109. Lynch Biologics Recent Development Table 110. MegaGen Impant Company Information Table 111. MegaGen Impant Business Overview Table 112. MegaGen Impant Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. MegaGen Impant Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 114. MegaGen Impant Recent Development Table 115. Neoss Limited Company Information Table 116. Neoss Limited Business Overview Table 117. Neoss Limited Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Neoss Limited Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 119. Neoss Limited Recent Development Table 120. Nobel Biocare Services/Danaher Corporation Company Information Table 121. Nobel Biocare Services/Danaher Corporation Business Overview Table 122. Nobel Biocare Services/Danaher Corporation Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Nobel Biocare Services/Danaher Corporation Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 124. Nobel Biocare Services/Danaher Corporation Recent Development Table 125. OraPharma Company Information Table 126. OraPharma Business Overview Table 127. OraPharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. OraPharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 129. OraPharma Recent Development Table 130. Salvin Dental Specialties，Inc Company Information Table 131. Salvin Dental Specialties，Inc Business Overview Table 132. Salvin Dental Specialties，Inc Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Salvin Dental Specialties，Inc Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 134. Salvin Dental Specialties，Inc Recent Development Table 135. Sunstar Company Information Table 136. Sunstar Business Overview Table 137. Sunstar Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Sunstar Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 139. Sunstar Recent Development Table 140. Yantai Zhenghai Bio-tech Company Information Table 141. Yantai Zhenghai Bio-tech Business Overview Table 142. Yantai Zhenghai Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Yantai Zhenghai Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 144. Yantai Zhenghai Bio-tech Recent Development Table 145. Zimmer Biomet Company Information Table 146. Zimmer Biomet Business Overview Table 147. Zimmer Biomet Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Zimmer Biomet Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 149. Zimmer Biomet Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Distributors List Table 153. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Image Figure 2. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales (2021-2032) & (K Units) Figure 5. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Absorbable Membrane Image Figure 10. Non-resorbable Membrane Image Figure 11. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Type (2021-2032) Figure 14. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type (2021-2032) Figure 17. Dental Image Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Application (2021-2032) Figure 24. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application (2021-2032) Figure 27. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032) & (US$ Million) Figure 32. North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032) & (US$ Million) Figure 38. South America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Oral Guided Bone Re

Scope & coverage.

Types
  • Absorbable Membrane
  • Non-resorbable Membrane
Applications
  • Dental
  • Hospital
  • Clinic
  • Other
Companies covered
  • Biomatlante
  • Biomedical Tissues
  • Bio-tech
  • Botiss
  • Dentsply Sirona
  • Geistlich Pharma
  • Genoss
  • Keystone Dental
  • Lynch Biologics
  • MegaGen Impant
  • Neoss Limited
  • Nobel Biocare Services/Danaher Corporation
  • OraPharma
  • Salvin Dental Specialties，Inc
  • Sunstar
  • Yantai Zhenghai Bio-tech
  • Zimmer Biomet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032)
  4. 1.2.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume (2021-2032)
  5. 1.2.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Dynamics
  1. 2.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Trends
  2. 2.2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Drivers
  3. 2.3 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Opportunities and Challenges
  4. 2.4 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Industry Restraints
3 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market by Company
  1. 3.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Company Revenue Ranking in 2025
  2. 3.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Revenue by Company (2021-2026)
  3. 3.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Company (2021-2026)
  4. 3.4 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Average Price by Company (2021-2026)
  5. 3.5 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Company Ranking (2024-2026)
  6. 3.6 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Company Manufacturing Base and Headquarters
  7. 3.7 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Company Product Type and Application
  8. 3.8 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market by Type
  1. 4.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Type Introduction
  2. 4.1.1 Absorbable Membrane
  3. 4.1.2 Non-resorbable Membrane
  4. 4.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type
  5. 4.2.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Type
  9. 4.3.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Type (2021-2032)
  11. 4.3.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type (2021-2032)
5 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market by Application
  1. 5.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Application Introduction
  2. 5.1.1 Dental
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.1.4 Other
  6. 5.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application
  7. 5.2.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Application
  11. 5.3.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Application (2021-2032)
  13. 5.3.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application (2021-2032)
6 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Regional Sales and Value Analysis
  1. 6.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region: 2021-2026
  4. 6.2.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Region (2027-2032)
  5. 6.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Region (2027-2032)
  9. 6.5 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032)
  12. 6.6.2 North America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032)
  15. 6.7.2 Europe Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032)
  21. 6.9.2 South America Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country, 2025 VS 2032
7 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Country-level Sales and Value Analysis
  1. 7.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Country (2021-2032)
  4. 7.3.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Country (2021-2026)
  5. 7.3.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales by Country (2027-2032)
  6. 7.4 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biomatlante
  2. 8.1.1 Biomatlante Company Information
  3. 8.1.2 Biomatlante Business Overview
  4. 8.1.3 Biomatlante Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Biomatlante Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  6. 8.1.5 Biomatlante Recent Developments
  7. 8.2 Biomedical Tissues
  8. 8.2.1 Biomedical Tissues Company Information
  9. 8.2.2 Biomedical Tissues Business Overview
  10. 8.2.3 Biomedical Tissues Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Biomedical Tissues Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  12. 8.2.5 Biomedical Tissues Recent Developments
  13. 8.3 Bio-tech
  14. 8.3.1 Bio-tech Company Information
  15. 8.3.2 Bio-tech Business Overview
  16. 8.3.3 Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  18. 8.3.5 Bio-tech Recent Developments
  19. 8.4 Botiss
  20. 8.4.1 Botiss Company Information
  21. 8.4.2 Botiss Business Overview
  22. 8.4.3 Botiss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Botiss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  24. 8.4.5 Botiss Recent Developments
  25. 8.5 Dentsply Sirona
  26. 8.5.1 Dentsply Sirona Company Information
  27. 8.5.2 Dentsply Sirona Business Overview
  28. 8.5.3 Dentsply Sirona Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Dentsply Sirona Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  30. 8.5.5 Dentsply Sirona Recent Developments
  31. 8.6 Geistlich Pharma
  32. 8.6.1 Geistlich Pharma Company Information
  33. 8.6.2 Geistlich Pharma Business Overview
  34. 8.6.3 Geistlich Pharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Geistlich Pharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  36. 8.6.5 Geistlich Pharma Recent Developments
  37. 8.7 Genoss
  38. 8.7.1 Genoss Company Information
  39. 8.7.2 Genoss Business Overview
  40. 8.7.3 Genoss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Genoss Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  42. 8.7.5 Genoss Recent Developments
  43. 8.8 Keystone Dental
  44. 8.8.1 Keystone Dental Company Information
  45. 8.8.2 Keystone Dental Business Overview
  46. 8.8.3 Keystone Dental Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Keystone Dental Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  48. 8.8.5 Keystone Dental Recent Developments
  49. 8.9 Lynch Biologics
  50. 8.9.1 Lynch Biologics Company Information
  51. 8.9.2 Lynch Biologics Business Overview
  52. 8.9.3 Lynch Biologics Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lynch Biologics Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  54. 8.9.5 Lynch Biologics Recent Developments
  55. 8.10 MegaGen Impant
  56. 8.10.1 MegaGen Impant Company Information
  57. 8.10.2 MegaGen Impant Business Overview
  58. 8.10.3 MegaGen Impant Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 MegaGen Impant Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  60. 8.10.5 MegaGen Impant Recent Developments
  61. 8.11 Neoss Limited
  62. 8.11.1 Neoss Limited Company Information
  63. 8.11.2 Neoss Limited Business Overview
  64. 8.11.3 Neoss Limited Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Neoss Limited Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  66. 8.11.5 Neoss Limited Recent Developments
  67. 8.12 Nobel Biocare Services/Danaher Corporation
  68. 8.12.1 Nobel Biocare Services/Danaher Corporation Company Information
  69. 8.12.2 Nobel Biocare Services/Danaher Corporation Business Overview
  70. 8.12.3 Nobel Biocare Services/Danaher Corporation Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Nobel Biocare Services/Danaher Corporation Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  72. 8.12.5 Nobel Biocare Services/Danaher Corporation Recent Developments
  73. 8.13 OraPharma
  74. 8.13.1 OraPharma Company Information
  75. 8.13.2 OraPharma Business Overview
  76. 8.13.3 OraPharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 OraPharma Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  78. 8.13.5 OraPharma Recent Developments
  79. 8.14 Salvin Dental Specialties，Inc
  80. 8.14.1 Salvin Dental Specialties，Inc Company Information
  81. 8.14.2 Salvin Dental Specialties，Inc Business Overview
  82. 8.14.3 Salvin Dental Specialties，Inc Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Salvin Dental Specialties，Inc Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  84. 8.14.5 Salvin Dental Specialties，Inc Recent Developments
  85. 8.15 Sunstar
  86. 8.15.1 Sunstar Company Information
  87. 8.15.2 Sunstar Business Overview
  88. 8.15.3 Sunstar Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Sunstar Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  90. 8.15.5 Sunstar Recent Developments
  91. 8.16 Yantai Zhenghai Bio-tech
  92. 8.16.1 Yantai Zhenghai Bio-tech Company Information
  93. 8.16.2 Yantai Zhenghai Bio-tech Business Overview
  94. 8.16.3 Yantai Zhenghai Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Yantai Zhenghai Bio-tech Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  96. 8.16.5 Yantai Zhenghai Bio-tech Recent Developments
  97. 8.17 Zimmer Biomet
  98. 8.17.1 Zimmer Biomet Company Information
  99. 8.17.2 Zimmer Biomet Business Overview
  100. 8.17.3 Zimmer Biomet Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Zimmer Biomet Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  102. 8.17.5 Zimmer Biomet Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Value Chain Analysis
  2. 9.1.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Mode & Process
  6. 9.2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Distributors
  9. 9.2.3 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst